These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 22219194)
1. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions. Shao B; Pennathur S; Heinecke JW J Biol Chem; 2012 Feb; 287(9):6375-86. PubMed ID: 22219194 [TBL] [Abstract][Full Text] [Related]
2. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. Shao B; Bergt C; Fu X; Green P; Voss JC; Oda MN; Oram JF; Heinecke JW J Biol Chem; 2005 Feb; 280(7):5983-93. PubMed ID: 15574409 [TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein. Jin Z; Zhou L; Tian R; Lu N Chem Res Toxicol; 2021 Jun; 34(6):1672-1680. PubMed ID: 33861588 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. Zheng L; Nukuna B; Brennan ML; Sun M; Goormastic M; Settle M; Schmitt D; Fu X; Thomson L; Fox PL; Ischiropoulos H; Smith JD; Kinter M; Hazen SL J Clin Invest; 2004 Aug; 114(4):529-41. PubMed ID: 15314690 [TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. Shao B; Oda MN; Bergt C; Fu X; Green PS; Brot N; Oram JF; Heinecke JW J Biol Chem; 2006 Apr; 281(14):9001-4. PubMed ID: 16497665 [TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein. Lu N; Xie S; Li J; Tian R; Peng YY Clin Chim Acta; 2015 Feb; 441():163-70. PubMed ID: 25528002 [TBL] [Abstract][Full Text] [Related]
7. Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL. Shao B Biochim Biophys Acta; 2012 Mar; 1821(3):490-501. PubMed ID: 22178192 [TBL] [Abstract][Full Text] [Related]
8. High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis. Vivekanandan-Giri A; Slocum JL; Byun J; Tang C; Sands RL; Gillespie BW; Heinecke JW; Saran R; Kaplan MJ; Pennathur S Ann Rheum Dis; 2013 Oct; 72(10):1725-31. PubMed ID: 23313808 [TBL] [Abstract][Full Text] [Related]
9. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages. Zheng L; Settle M; Brubaker G; Schmitt D; Hazen SL; Smith JD; Kinter M J Biol Chem; 2005 Jan; 280(1):38-47. PubMed ID: 15498770 [TBL] [Abstract][Full Text] [Related]
10. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease. Shao B; Oda MN; Vaisar T; Oram JF; Heinecke JW Curr Opin Mol Ther; 2006 Jun; 8(3):198-205. PubMed ID: 16774039 [TBL] [Abstract][Full Text] [Related]
11. Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway. Shao B; Heinecke JW J Proteomics; 2011 Oct; 74(11):2289-99. PubMed ID: 21501700 [TBL] [Abstract][Full Text] [Related]